A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components

Annals of Hematology

Volumn 92, Issue 6, 2013, Pages 807-815

  Li, Xiaowu ^a   Xia, Bing ^a   Guo, Shanqi ^a   Zhan, Zhongli ^a   Zhang, Lianyu ^a   Zhao, Dandan ^b   Wu, Xiaoxiong ^b   Zhang, Yizhuo ^a  

^a KEY LABORATORY OF CANCER PREVENTION AND THERAPY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diffuse large B cell lymphoma; Gastric; Mucosa associated lymphoid tissue; Prognostic factor; Treatment

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PREDNISONE; RABEPRAZOLE; RITUXIMAB; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; HELICOBACTER INFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNATIONAL PROGNOSTIC INDEX; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; STOMACH LYMPHOMA; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHINA; COMORBIDITY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; GASTRECTOMY; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME; VINCRISTINE; YOUNG ADULT;

EID: 84877766909     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1701-9     Document Type: Article

References (33)

1. Ghimire P, Wu GY, Zhu L (2011) Primary gastrointestinal lymphoma. World J Gastroenterol 17:697-707
2. Arora N, Manipadam MT, Pulimood A, Ramakrishna BS, Chacko A, Kurian SS, Nair S (2011) Gastrointestinal lymphomas: pattern of distribution and histological subtypes: 10 years experience in a tertiary centre in South India. Indian J Pathol Microbiol 54:712-719
3. Nakamura S, Ye H, Bacon CM, Goatly A, Liu H, Kerr L, Banham AH, Streubel B, Yao T, Tsuneyoshi M, Savio A, Takeshita M, Dartigues P, Ruskone-Fourmestraux A, Matsumoto T, Iida M, Du MQ (2008) Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma. Clin Cancer Res 14:3002-3010
4. Yoshino T, Omonishi K, Kobayashi K, Mannami T, Okada H, Mizuno M, Yamadori I, Kondo E, Akagi T (2000) Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features. J Clin Pathol 53:187-190
5. Tomonaga M (2009) Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues. Rinsho Ketsueki 50:1401-1406
6. Kuo SH, Yeh KH, Wu MS, Lin CW, Hsu PN, Wang HP, Chen LT, Cheng AL (2012) Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood 119:4838-4844, quiz 5057
7. Zhang J, Li G, Yang H, Yang H, Liu X, Cao J (2012) Rituximab in treatment of primary gastric diffuse large B-cell lymphoma. Leuk Lymphoma 53(11):2175-2181
8. Sbitti Y, Ismaili N, Bensouda Y, Kadiri H, Ichou M, Errihani H (2010) Management of stage one and two-E gastric large B-cell lymphoma: chemotherapy alone or surgery followed by chemotherapy. J Hematol Oncol 3:23
9. Ferrucci PF, Zucca E (2007) Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years. Br J Haematol 136:521-538
10. Psyrri A, Papageorgiou S, Economopoulos T (2008) Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol 19:1992-1999
11. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282
12. Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5:397-400
13. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244
14. Tari A, Asaoku H, Kashiwado K, Yoshino T, Kitadai Y, Tanaka S, Fujihara M (2009) Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication. Dig Endosc 21:219-227
15. Flossbach L, Kestler HA, Gress TM, Moller P, Barth TF (2010) Current aspects of the pathology and differentiation of extranodal marginal zone B-cell lymphoma, MALT-Type, and gastrointestinal diffuse large B-cell lymphoma. Z Gastroenterol 48:833-838
16. Huang J, Jiang W, Xu R, Huang H, Lv Y, Xia Z, Sun X, Guan Z, Lin T, Li Z (2010) Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors. BMC Cancer 10:358
17. Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N, Chiba T, Origasa H, Asaka M (2012) Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61:507-513
18. Binn M, Ruskone-Fourmestraux A, Lepage E, Haioun C, Delmer A, Aegerter P, Lavergne A, Guettier C, Delchier JC (2003) Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 14:1751-1757
19. Hawkes EA, Wotherspoon A, Cunningham D (2012) Diagnosis and management of rare gastrointestinal lymphomas. Leuk Lymphoma 53(12):2341-2350
20. Wohrer S, Puspok A, Drach J, Hejna M, Chott A, Raderer M (2004) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol 15:1086-1090
21. Leopardo D, Di LG, De Renzo A, Federico P, Luponio S, Buonerba C, Matano E, Merola G, Imbimbo M, Montesarchio E, Rea A, Merola MC, De Placido S, Palmieri G (2010) Efficacy of rituximab in gastric diffuse large B cell lymphoma patients. World J Gastroenterol 16:2526-2530
22. Ibrahim EM, Ezzat AA, Raja MA, Rahal MM, Ajarim DS, Mann B, Baloush A, Stuart RK, Bazarbashi SN (1999) Primary gastric non-Hodgkin's lymphoma: clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma. Ann Oncol 10:1441-1449
23. Castrillo JM, Montalban C, Abraira V, Carrion R, Cruz MA, Larana JG, Menarguez J, Bellas C, Piris MA, Gomez-Marcos F, Serrano M, Rivas C (1996) Evaluation of the international index in the prognosis of high grade gastric malt lymphoma. Leuk Lymphoma 24:159-163
24. Cortelazzo S, Rossi A, Roggero F, Oldani E, Zucca E, Tondini C, Ambrosetti A, Pasini F, Pinotti G, Bertini M, Vitolo U, Busetto M, Gianni L, Cavalli F, Barbui T (1999) Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG). Ann Oncol 10:1433-1440
25. van Imhoff GW, Boerma EJ, van der Holt B, Schuuring E, Verdonck LF, Kluin-Nelemans HC, Kluin PM (2006) Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. J Clin Oncol 24:4135-4142
26. Muris JJ, Meijer CJ, Vos W, van Krieken JH, Jiwa NM, Ossenkoppele GJ, Oudejans JJ (2006) Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol 208:714-723
27. Takeshita M, Iwashita A, Kurihara K, Ikejiri K, Higashi H, Udoh T, Kikuchi M (2000) Histologic and immunohistologic findings and prognosis of 40 cases of gastric large B-cell lymphoma. Am J Surg Pathol 24:1641-1649
28. Ponzoni M, Ferreri AJ, Pruneri G, Pozzi B, Dell'Oro S, Pigni A, Pinotti G, Villa E, Freschi M, Viale G, Capella C (2003) Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome. Int J Cancer 106:288-291
29. Medina-Franco H, Germes SS, Maldonado CL (2007) Prognostic factors in primary gastric lymphoma. Ann Surg Oncol 14:2239-2245
30. Ranaldi R, Goteri G, Baccarini MG, Mannello B, Bearzi I (2002) A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. J Clin Pathol 55:346-351
31. Freedman AS (2005) Biology and management of histologic transformation of indolent lymphoma. Hematology Am Soc Hematol Educ Program 314-320
32. Montoto S, Fitzgibbon J (2011) Transformation of indolent B-cell lymphomas. J Clin Oncol 29:1827-1834
33. Hiyama T, Haruma K, Kitadai Y, Masuda H, Miyamoto M, Ito M, Kamada T, Tanaka S, Uemura N, Yoshihara M, Sumii K, Shimamoto F, Chayama K (2001) Clinicopathological features of gastric mucosa-associated lymphoid tissue lymphoma: a comparison with diffuse large B-cell lymphoma without a mucosa-associated lymphoid tissue lymphoma component. J Gastroenterol Hepatol 16:734-739